RIZZELLO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 786
EU - Europa 691
AS - Asia 335
AF - Africa 41
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.859
Nazione #
US - Stati Uniti d'America 781
IT - Italia 276
CN - Cina 130
SG - Singapore 127
GB - Regno Unito 87
DE - Germania 78
SE - Svezia 72
IN - India 42
IE - Irlanda 36
RU - Federazione Russa 28
CI - Costa d'Avorio 20
AT - Austria 16
BG - Bulgaria 15
NL - Olanda 14
FR - Francia 13
TG - Togo 13
FI - Finlandia 11
ES - Italia 10
ID - Indonesia 8
JO - Giordania 8
UA - Ucraina 8
PH - Filippine 7
CH - Svizzera 6
EE - Estonia 6
CA - Canada 5
HK - Hong Kong 5
ZA - Sudafrica 5
BE - Belgio 4
CZ - Repubblica Ceca 4
NG - Nigeria 3
TR - Turchia 3
BR - Brasile 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
CY - Cipro 1
GR - Grecia 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 1.859
Città #
Chandler 122
Singapore 107
Bologna 95
Southend 73
Ashburn 68
Fairfield 63
Santa Clara 41
Dublin 36
Woodbridge 31
Wilmington 27
Boardman 25
Seattle 25
Houston 24
Princeton 24
Hyderabad 22
Cambridge 21
Abidjan 20
Milan 17
Ann Arbor 16
New York 16
Sofia 15
Fabriano 14
Turin 14
Bremen 13
Lomé 13
Redmond 13
Beijing 12
Vienna 12
Helsinki 10
Amsterdam 9
Los Angeles 9
Nanjing 9
Amman 8
Jakarta 8
Berlin 7
Florence 7
Bern 6
Dearborn 6
Nanchang 6
Nuremberg 6
Padova 6
Shanghai 6
Westminster 6
Hong Kong 5
Munich 5
Redwood City 5
Riola 5
San Diego 5
Yubileyny 5
Zhengzhou 5
Anoia Superiore 4
Changsha 4
Falls Church 4
Shenyang 4
York 4
Abeokuta 3
Boydton 3
Brussels 3
Cagliari 3
Des Moines 3
Fuzhou 3
Guangzhou 3
Javea 3
Paris 3
Pianoro 3
Rome 3
Saint Petersburg 3
Springfield 3
Stilo 3
Toronto 3
Verona 3
Wuhan 3
Ankara 2
Bari 2
Belgrade 2
Bodio Lomnago 2
Brno 2
Brookline 2
Chongqing 2
Donostia / San Sebastian 2
Frankfurt am Main 2
Hockenheim 2
Kiel 2
Kiev 2
Kilburn 2
Leawood 2
Livorno 2
Manchester 2
Medford 2
Naples 2
Palma 2
Parma 2
Pisa 2
Poggio Renatico 2
Pune 2
Rochester 2
San Francisco 2
Tianjin 2
Treviso 2
Vado Ligure 2
Totale 1.250
Nome #
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 143
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma 137
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 136
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 126
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 124
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 124
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 119
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia 118
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 114
null 98
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients 91
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients 78
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 74
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 62
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 53
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma 49
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 44
null 39
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 37
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review 33
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 31
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight 31
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 25
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 24
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 15
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 13
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 13
Totale 1.951
Categoria #
all - tutte 7.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 0 0 28 23 12 18 4
2020/2021103 21 4 6 3 2 7 2 13 15 6 10 14
2021/2022301 7 13 15 37 14 12 12 25 16 46 56 48
2022/2023498 40 53 19 81 43 41 17 19 83 18 48 36
2023/2024263 17 29 15 19 18 53 9 55 6 17 17 8
2024/2025527 70 68 97 101 78 32 72 9 0 0 0 0
Totale 1.951